  |
| Mike Henos is the founder and Managing General Partner
of Alliance Technology Ventures. He focuses on investments in biotechnology and personalized medicine.
Mike has successfully invested in several private companies which
have gone on to become public corporations. Among these investments
are Adeza Biomedical, Amylin Pharmaceuticals, AtheroGenics, Inhibitex, Keravision, Ligand Pharmaceuticals,
and RF Micro Devices. Mr. Henos is presently Chairman of the
Board of AtheroGenics and Inhibitex, both based in Alpharetta,
Georgia. He currently serves as a director of ATV portfolio companies Genoptix, GlycoMimetics, Neuronyx,
Sensys Medical and
ValuBond. He also is responsible for ATV's investment in Aderis Pharmaceuticals.
Mike brings nearly nineteen years of accomplished venture capital
experience. Prior to ATV, he was a General Partner with Aspen Venture
Partners, where he was based in Menlo Park, CA. Prior to Aspen he
was Vice President of 3i Ventures in Newport Beach, CA. From 1984
to 1986, he was a health care consultant with Ernst & Young, specializing
in venture financing of start-up medical technology companies. Prior
to 1984, Mike served in a variety of management positions with Science
Applications, the Revlon Healthcare Group and
co-founded Pro Med Technologies, where he also served as its Chief
Executive Officer. Mike earned a BS in economics and an MBA from the
University of California at Los Angeles (UCLA).
Back |
|